These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 13643481)

  • 21. Quantitative measurement of therapy in paralysis agitans.
    AGATE FJ; DOSHAY LJ; CURTIS FK
    J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202
    [No Abstract]   [Full Text] [Related]  

  • 22. Antispasmodic compound 08958 in treatment of paralysis agitans.
    MAGEE KR; DEJONG RN
    J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281
    [No Abstract]   [Full Text] [Related]  

  • 23. Preliminary study of a new anti-parkinson agent.
    DOSHAY LJ; CONSTABLE K; FROMER S
    Neurology; 1952; 2(3):233-43. PubMed ID: 14929300
    [No Abstract]   [Full Text] [Related]  

  • 24. Concurrent paralysis agitans and schizophrenia. Confusion with drug-induced extrapyramidal disorders.
    HOLLISTER LE; GLAZENER FS
    Dis Nerv Syst; 1961 Apr; 22():187-9. PubMed ID: 13715372
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aturban (phenglutarimide), a new therapeutic drug for parkinsonism; comparative investigation on the therapy of parkinsonism].
    BATTEGAY R
    Schweiz Med Wochenschr; 1958 Jul; 88(30):740-2. PubMed ID: 13580191
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with a new drug for control of parkinsonism, keithon].
    FINKE H
    Medizinische; 1959 Apr; 4(15):741-2. PubMed ID: 13656300
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.
    DOSHAY LJ; CONSTABLE K; AGATE FJ
    J Am Med Assoc; 1956 Feb; 160(5):348-51. PubMed ID: 13278201
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
    KIRCHHOF JK
    Nervenarzt; 1956 Oct; 27(10):447-53. PubMed ID: 13387960
    [No Abstract]   [Full Text] [Related]  

  • 29. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans.
    DOSHAY LJ
    J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic activity of a new drug, M.G. 1229, 4-(gamma-diethylaminopropyl)-hydroxydiphenylethane, in the parkinsonian syndrome].
    DONATI A; MORI G
    Gazz Med Ital; 1956 Oct; 115(10):331-4. PubMed ID: 13384655
    [No Abstract]   [Full Text] [Related]  

  • 31. Kemadrin, a new drug for treatment of Parkinsonian disease.
    LERNER PF
    J Nerv Ment Dis; 1956 Jan; 123(1):79-82. PubMed ID: 13346366
    [No Abstract]   [Full Text] [Related]  

  • 32. Parsidol in the treatment of Parkinson's syndrome.
    SOBUE I; IVES ER
    Bull Los Angel Neuro Soc; 1956 Jun; 21(2):80-3. PubMed ID: 13329559
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trials of transergan in the parkinsonian syndrome.
    ELIASSON S; TEJNING S
    Acta Med Scand; 1956 Jun; 154(5):375-9. PubMed ID: 13326279
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative research on new drugs for the treatment of extrapyramidal motor disorders].
    KUVER G
    Medizinische; 1955 Oct; (42):1471-4. PubMed ID: 13287617
    [No Abstract]   [Full Text] [Related]  

  • 35. [Activity of kemadrin on the symptoms of Parkinson's disease; comparison with other therapeutics].
    SIGWALD J
    Presse Med (1893); 1953 Jan; 61(7):127-8. PubMed ID: 13055735
    [No Abstract]   [Full Text] [Related]  

  • 36. [Keithon for therapy of parkinsonism].
    Med Monatsschr; 1957 Dec; 11(12):833. PubMed ID: 13503612
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicinal treatment of parkinsonism.
    WERNER H
    Wien Med Wochenschr; 1959 May; 109(22):469-71. PubMed ID: 13669477
    [No Abstract]   [Full Text] [Related]  

  • 38. [Benztropine methanesulfonate in the treatment of parkinsonism].
    BRAGE D
    Prensa Med Argent; 1956 Dec; 43(50):3687-90. PubMed ID: 13431663
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations in treatment of parkinsonism with aturban.
    ECKEL K; HARRER G
    Wien Med Wochenschr; 1959 May; 109(18):391-3. PubMed ID: 13660041
    [No Abstract]   [Full Text] [Related]  

  • 40. [An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12].
    HARDER A; PRELICZ T
    Schweiz Med Wochenschr; 1956 Mar; 86(13):335-8. PubMed ID: 13337189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.